In the HealthTech business segment, MT Group Switzerland distributes an innovative device for interval hypoxia-hyperoxia therapy (IHHT) worldwide and supports its successful introduction into the medical, sports and therapeutic markets. We combine medical knowledge, technological expertise and entrepreneurial thinking to make its use efficient, safe and effective – with a focus on quality, user-friendliness and sustainable added value for patients and partners.